Health News Releases

  • Today December 21
May 09, 2017 13:30
Takeda Announces Publication of ALUNBRIG™ (brigatinib) Pivotal Phase 2 ALTA Clinical Trial Data in Journal of Clinical Oncology
Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that data from the pivotal Phase 2 ALTA (ALK in Lung Cancer Trial of AP26113) clinical trial evaluating ALUNBRIG™ (brigatinib) in pati
May 04, 2017 17:10
Athersys Partnering With MedCision on High-Volume ThawSTAR Cell Thawing Systems for Use in Clinical Trials
MedCision, LLC., the world leader in the automation of cell thawing, and Athersys, Inc., a clinical-stage biotechnology company developing proprietary cell therapies, have formed a strategic partnersh
May 01, 2017 14:00
Takeda Announces FDA Accelerated Approval of ALUNBRIG™ (brigatinib)
Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that ALUNBRIG™ (brigatinib) has received Accelerated Approval from the U.S. Food and Drug Administration (FDA) for the treatment of pa
April 20, 2017 23:05
Replicor discloses achievement of 1 year functional control of HBV and HDV with NAPs and new mechanistic insights in NAP pharmacology
Replicor Inc., a privately held biopharmaceutical company targeting a cure for chronic HBV and HDV infection, today disclosed significant new data on NAP activity in HBV and HDV infections at the Euro
April 19, 2017 13:50
Synexus to Advance Capabilities as World’s Leading Site Network
European-headquartered Synexus and U.S.-based Radiant Research today announced a full operational integration to form a single global site network of 185 sites with 1,500 employees. This move will cre
April 12, 2017 17:00
PSMF Invites International Patient Safety Community to Attend its 5th Annual Midyear Planning Meeting on July 13, 2017
The Patient Safety Movement Foundation (PSMF) invites patient safety experts, medical care providers, hospital administrators, patient advocates and policy makers from around the world to discuss chal
April 12, 2017 13:30
Low-Level Light Therapy Accelerates Hair Growth in Chemotherapy Patients
Photobiomodulation therapy, or low-level light therapy (LLLT), has been shown to accelerate hair recovery by 2.6x in patients with chemotherapy-induced alopecia (CIA), according to preliminary finding
April 11, 2017 13:45
Fresenius Medical Care AG & Co. KGaA Published Form 20-F for the Fiscal Year 2016
Fresenius Medical Care AG & Co. KGaA (“the company” or “Fresenius Medical Care”), the world‘s largest provider of dialysis products and services, announced that it has filed the annual report 2016 und
April 11, 2017 11:45
Takeda Enters into Strategic Collaboration with NuBiyota for Microbiome Therapeutics
Takeda Pharmaceutical Company Limited (TOKYO:4502) today announced a strategic collaboration with NuBiyota LLC for the development of Microbial Ecosystem Therapeutic products for gastroenterology (GI)
April 11, 2017 10:15
Ferring Announces Exclusive Agreement with Alrise Biosystems for the Development of an Injectable, Controlled-Release Peptide
Ferring Pharmaceuticals and Alrise Biosystems announced today that the companies have entered into a development agreement with exclusive option rights for Ferring to leverage Alrise’s ImSus® Technolo
April 07, 2017 11:05
Ferring Highlights Progress on Social and Environmental Goals in Corporate Social Responsibility (CSR) Review 2015-2016
Ferring Pharmaceuticals releases its second Corporate Social Responsibility (CSR) review, highlighting progress on social and environmental goals in 2015 and 2016 across four key pillars for focus and
April 06, 2017 12:00
Herbalife Nutrition Study Reveals Alarming Lack of Nutrition, Hydration and Exercise among Adults
Herbalife, a global nutrition company, has released the findings from its Asia Pacific Balanced Nutrition Survey[1], which focuses on shedding light on nutrition and health habits, behaviors and attit
April 06, 2017 10:55
Takeda Completes Enrollment of More Than 20,000 Children and Adolescents in Global Phase 3 Trial of Dengue Vaccine Candidate
Takeda Pharmaceutical Company Limited [TSE: 4502], (“Takeda”) today announced that it has completed enrollment of 20,100 children and adolescents ages 4 through 16 in its global, pivotal Phase 3 Tetra
April 06, 2017 10:45
Boehringer Ingelheim: A New World Leader in Animal Health
Three months after acquiring animal health leader Merial in a strategic transaction with Sanofi, Boehringer Ingelheim revealed its ambition to compete for industry leadership worldwide in animal healt
April 04, 2017 13:40
Patient Safety Movement Foundation Announces 3rd Annual Patient Safety Innovation Awards
The Patient Safety Movement Foundation (PSMF) announces the 3rd Annual Patient Safety Innovation Awards will open on April 3, 2017 at 12:00 PM PDT. The competition encourages entrepreneurs and patient
April 04, 2017 09:35
Ferring Appoints Dominic Moorhead as Executive Vice President and Chief Financial Officer
Ferring Pharmaceuticals announced today that Dominic Moorhead has been appointed as Executive Vice President and Chief Financial Officer, effective 1st July 2017. Moorhead succeeds Peter Wilden, wh
March 31, 2017 14:00
IncellDx Releases CE-IVD Quantitative Single Cell PD-L1 OncoTect iO® Assay
IncellDx, Inc. announces the release of their CE marked OncoTect iO® Lung Kit today, March 30, 2017, entering the immunotherapeutic diagnostic market in Europe and countries that accept the CE- mark a
March 31, 2017 13:00
Takeda Announces Ricardo Marek as New President of Emerging Markets Business Unit
Takeda Pharmaceuticals Company Limited (“Takeda”), announced today that Ricardo Marek has been appointed as the President of the Emerging Markets Business Unit (EM BU), based in Singapore, effective A
March 30, 2017 09:25
Takeda’s Dengue Vaccine Candidate Elicited Broad Immune Responses in Children and Adolescents Living in Dengue-Endemic Areas; Interim Phase 2 Analysis Published in The Lancet Infectious Diseases
Takeda Pharmaceutical Company Limited [TSE: 4502], (“Takeda”) today announced that data from a 6-month interim analysis* of the ongoing DEN-204 trial of its live-attenuated tetravalent dengue vaccine
March 29, 2017 13:50
Heliae Announces First Use of Branded TruAzta Natural Astaxanthin
Heliae, in collaboration with Madre Labs Inc., today announced California GOLD Nutrition Astaxanthin supplement caps branded with a TruAzta™ logo are now available on iHerb.com. This Smart News Rel
March 27, 2017 09:35
China's Healthcare Market to See Surge of Investment and Opportunities in Next 15 Years
Last October, the Chinese government approved a blueprint called “Healthy China 2030”, pledging to build a healthy China in the next 15 years. By 2030, the size of the healthcare market is expected to
March 21, 2017 14:00
Masimo Announces CE Marking of Rad-97™ Pulse CO-Oximeter® and Connectivity Hub with Noninvasive Blood Pressure
Masimo (NASDAQ: MASI) announced today the CE marking of noninvasive blood pressure (NIBP) measurements for the Rad-97™ Pulse CO-Oximeter® and connectivity hub. Rad-97 offers Measure-through Motion and
March 20, 2017 17:35
Uninterrupted Pradaxa® Showed Less Major Bleeding than Warfarin in Atrial Fibrillation Patients Undergoing Catheter Ablation
Important new data from the RE-CIRCUIT® study show a better safety profile for Pradaxa® (dabigatran etexilate) compared to warfarin in atrial fibrillation (AF) patients undergoing catheter ablation. A
March 20, 2017 09:25
First dedicated outcome trials of empagliflozin in chronic heart failure initiated
Boehringer Ingelheim and Eli Lilly and Company (NYSE: LLY) today announced that the EMPEROR HF clinical trial programme was initiated. EMPEROR HF comprises two Phase III outcome studies that will inve
March 17, 2017 13:55
Ferring Pharmaceuticals: Waking up to Go to the Toilet is the Number One Cause of a Poor Night’s Sleep, Say Experts on World Sleep Day
On World Sleep Day sleep experts encourage people to understand the value of healthy and solid sleep. In particular, if they need to go to the toilet more than once in the night they have nocturia, a
25 per page50 per page75 per page100 per page